TCI Wealth Advisors, Inc. - CORVUS PHARMACEUTICALS INC ownership

CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 65 filers reported holding CORVUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$455
+7.1%
5000.0%0.00%
Q4 2022$425
-57.5%
500
-37.5%
0.00%
Q3 2022$1,0000.0%8000.0%0.00%
Q2 2022$1,0000.0%800
+100.0%
0.00%
Q1 2022$1,0000.0%4000.0%0.00%
Q4 2021$1,0000.0%400
+33.3%
0.00%
Q3 2021$1,0003000.00%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 3,275,616$28,105,0004.42%
Novo Holdings A/S 4,420,516$37,928,0003.01%
BVF INC/IL 1,890,507$16,221,0001.42%
Orbimed Advisors 5,967,584$51,202,0000.62%
COWEN INC. 588,706$5,051,0000.46%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 108,000$710,0000.34%
SPHERA FUNDS MANAGEMENT LTD. 321,430$2,758,0000.32%
EcoR1 Capital, LLC 351,401$3,015,0000.27%
Rock Springs Capital Management LP 575,000$4,934,0000.18%
Hikari Power Ltd 32,090$275,0000.03%
View complete list of CORVUS PHARMACEUTICALS INC shareholders